News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
607,753 Results
Type
Article (39758)
Company Profile (135)
Press Release (567836)
Multimedia
Podcasts (121)
Webinars (28)
Section
Business (166556)
Career Advice (1751)
Deals (27704)
Drug Delivery (108)
Drug Development (66564)
Employer Resources (155)
FDA (15088)
Job Trends (13069)
News (282505)
Policy (26851)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2446)
Accelerated approval (40)
Adcomms (18)
Allergies (166)
Alliances (43332)
ALS (193)
Alzheimer's disease (1610)
Antibody-drug conjugate (ADC) (431)
Approvals (15606)
Artificial intelligence (712)
Autoimmune disease (297)
Automation (53)
Bankruptcy (203)
Best Places to Work (10259)
BIOSECURE Act (20)
Biosimilars (185)
Biotechnology (87)
Bladder cancer (185)
Brain cancer (63)
Breast cancer (696)
Cancer (5434)
Cardiovascular disease (431)
Career advice (1506)
Career pathing (45)
CAR-T (296)
CDC (52)
Celiac Disease (3)
Cell therapy (839)
Cervical cancer (49)
Clinical research (59109)
Collaboration (1988)
Company closure (4)
Compensation (862)
Complete response letters (57)
COVID-19 (2220)
CRISPR (100)
C-suite (1150)
Cystic fibrosis (118)
Data (7623)
Decentralized trials (3)
Denatured (49)
Depression (156)
Dermatology (83)
Diabetes (555)
Diagnostics (5833)
Digital health (56)
Diversity (12)
Diversity, equity & inclusion (39)
Drug discovery (310)
Drug pricing (191)
Drug shortages (32)
Duchenne muscular dystrophy (234)
Earnings (63253)
Editorial (70)
Employer branding (18)
Employer resources (135)
Events (93744)
Executive appointments (1113)
FDA (18757)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (32)
Funding (1646)
Gene editing (198)
Generative AI (63)
Gene therapy (629)
GLP-1 (933)
Government (4130)
Grass and pollen (6)
Guidances (388)
Healthcare (16838)
HIV (73)
Huntington's disease (41)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (84)
Immunology and inflammation (188)
Immuno-oncology (83)
Indications (188)
Infectious disease (2516)
Inflammatory bowel disease (204)
Inflation Reduction Act (15)
Influenza (115)
Intellectual property (248)
Interviews (302)
IPO (11776)
IRA (53)
Job creations (3109)
Job search strategy (1268)
JPM (58)
Kidney cancer (16)
Labor market (95)
Layoffs (407)
Leadership (42)
Legal (5678)
Liver cancer (92)
Longevity (28)
Lung cancer (752)
Lymphoma (388)
Machine learning (62)
Management (48)
Manufacturing (960)
MASH (189)
Medical device (14364)
Medtech (14497)
Mergers & acquisitions (17121)
Metabolic disorders (1368)
mRNA (181)
Multiple sclerosis (179)
NASH (16)
Neurodegenerative disease (375)
Neuropsychiatric disorders (90)
Neuroscience (2999)
NextGen: Class of 2026 (5841)
Non-profit (3918)
Now hiring (63)
Obesity (595)
Opinion (311)
Ovarian cancer (219)
Pain (237)
Pancreatic cancer (270)
Parkinson's disease (352)
Partnered (30)
Patents (498)
Patient recruitment (654)
Peanut (55)
People (57321)
Pharmaceutical (34)
Pharmacy benefit managers (31)
Phase 1 (18231)
Phase 2 (25969)
Phase 3 (19856)
Pipeline (8418)
Policy (298)
Postmarket research (2026)
Preclinical (7473)
Press Release (69)
Prostate cancer (296)
Psychedelics (44)
Radiopharmaceuticals (300)
Rare diseases (913)
Real estate (5312)
Recruiting (66)
Regulatory (21965)
Reports (50)
Research institute (2350)
Resumes & cover letters (270)
Rett syndrome (39)
RNA editing (14)
RSV (76)
Schizophrenia (170)
Series A (269)
Series B (198)
Service/supplier (6)
Sickle cell disease (101)
Special edition (22)
Spinal muscular atrophy (151)
Sponsored (36)
Startups (3313)
State (1)
Stomach cancer (16)
Supply chain (115)
Tariffs (93)
The Weekly (70)
Vaccines (902)
Venture capital (96)
Weight loss (383)
Women's health (113)
Worklife (18)
Date
Today (165)
Last 7 days (516)
Last 30 days (3040)
Last 365 days (26724)
2026 (11764)
2025 (27051)
2024 (30506)
2023 (34524)
2022 (45142)
2021 (48607)
2020 (47068)
2019 (41799)
2018 (31645)
2017 (28277)
2016 (27513)
2015 (31954)
2014 (24316)
2013 (20513)
2012 (22154)
2011 (22709)
2010 (20616)
Location
Africa (693)
Alabama (74)
Alaska (6)
Arizona (296)
Arkansas (16)
Asia (42451)
Australia (6491)
California (11730)
Canada (3276)
China (1367)
Colorado (495)
Connecticut (557)
Delaware (403)
Europe (81250)
Florida (1643)
Georgia (361)
Hawaii (3)
Idaho (55)
Illinois (1017)
India (82)
Indiana (560)
Iowa (22)
Japan (555)
Kansas (123)
Kentucky (45)
Louisiana (42)
Maine (42)
Maryland (1403)
Massachusetts (8305)
Michigan (336)
Minnesota (670)
Mississippi (6)
Missouri (120)
Montana (32)
Nebraska (27)
Nevada (129)
New Hampshire (86)
New Jersey (3241)
New Mexico (24)
New York (3141)
North Carolina (1521)
North Dakota (11)
Northern California (5855)
Ohio (395)
Oklahoma (25)
Oregon (40)
Pennsylvania (2312)
Puerto Rico (22)
Rhode Island (46)
South America (977)
South Carolina (86)
South Dakota (1)
Southern California (4648)
Tennessee (200)
Texas (1914)
United States (41784)
Utah (368)
Vermont (1)
Virginia (286)
Washington D.C. (80)
Washington State (933)
West Virginia (4)
Wisconsin (141)
Wyoming (2)
607,753 Results for "d medical industries ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tenpoint Therapeutics, Ltd. Appoints Stephen S. Lane, M.D., as Chief Medical Officer
April 7, 2026
·
3 min read
Press Releases
Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
May 7, 2026
·
6 min read
Press Releases
Taiwan-Based Towards Buddha Co., Ltd. Showcases Medical-Grade TPU Tubing Injection Solutions at Medtec Japan 2026
April 9, 2026
·
2 min read
Press Releases
Faron Pharmaceuticals Ltd: Directorate Appointment
May 5, 2026
·
3 min read
Press Releases
LeonaBio to Participate in Upcoming Medical and Industry Meetings in June 2026
May 27, 2026
·
1 min read
Press Releases
Delphia Therapeutics Appoints David P. Kerstein, M.D., as Chief Medical Officer
May 26, 2026
·
2 min read
Press Releases
OS Therapies to Attend Upcoming Medical, Financial and Industry Conferences
• ASCO 2026: 2.5-Year Overall Survival Data • Jefferies Healthcare Conference: Partnering & Investor meetings • BIO International Convention: Panel Participation • MIB Agents Factor Osteosarcoma Conference: Data Presentation
May 26, 2026
·
4 min read
Press Releases
Sail Biomedicines Appoints Gene Marcantonio, M.D., Ph.D., as Chief Medical Officer
May 5, 2026
·
3 min read
Press Releases
OS Therapies Appoints Industry Leader Dr. Craig Eagle as Chief Medical Advisor
• Appointment strengthens medical, regulatory, and commercial leadership as Company prepares to complete early market access regulatory filings in the U.S., U.K, Europe and Australia in anticipation of OST-HER2 approval decisions expected by year-end 2026 • Upcoming FDA Pre-BLA meeting will focus on the use of recent seroconversion biomarker data as a key surrogate clinical efficacy endpoint to support a BLA for OST-HER2 under the Accelerated Approval Program • Commercialization and reimbursement preparations well underway for the U.S., U.K., and Europe in parallel with ongoing partnership discussions
May 14, 2026
·
7 min read
Press Releases
NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes
May 27, 2026
·
6 min read
1 of 60,776
Next
